Palomino Laboratories Inc.
PALX
OTC PK
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.96M | 360.40K | 183.20K | 6.00K | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.96M | 360.40K | 183.20K | 6.00K | -- |
| Operating Income | -1.96M | -360.40K | -183.20K | -6.00K | -- |
| Income Before Tax | -2.43M | -612.10K | -314.20K | -16.20K | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.43 | -0.61 | -0.31 | -0.02 | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.43M | -612.10K | -314.20K | -16.20K | -- |
| EBIT | -1.96M | -360.40K | -183.20K | -6.00K | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.73 | -0.19 | -0.10 | -0.01 | -- |
| Normalized Basic EPS | -0.45 | -0.12 | -0.06 | 0.00 | -- |
| EPS Diluted | -0.73 | -0.20 | -0.10 | -0.01 | -- |
| Normalized Diluted EPS | -0.45 | -0.12 | -0.06 | 0.00 | -- |
| Average Basic Shares Outstanding | 13.78M | 12.06M | 10.50M | 8.95M | -- |
| Average Diluted Shares Outstanding | 13.78M | 12.06M | 14.85M | 17.64M | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |